Skip to main content
Journal cover image

Hepatocellular carcinoma in patients with no identifiable risk factors.

Publication ,  Journal Article
McIntyre, CA; Chou, JF; Gonen, M; Shia, J; Gambarin-Gelwan, M; Balachandran, VP; Kingham, TP; Allen, PJ; Drebin, JA; Jarnagin, WR; D'Angelica, MI
Published in: HPB (Oxford)
January 2021

BACKGROUND: A subset of patients have no risk factors for the development of hepatocellular carcinoma (HCC). We evaluated differences in clinical variables between patients with and without risk factors who underwent surgical resection. METHODS: A prospectively maintained database was queried for patients who underwent R0/R1 resection of HCC between 1992 and 2016. Risk factors included HCV, HBV, hemochromatosis, alcoholic liver disease, or cirrhosis, stage 2 or 3 fibrosis or severe (>66%) steatosis of the non-neoplastic liver. Variables were compared between patients with and without risk factors. RESULTS: There were 416 patients who underwent resection; 276 (66%) had known risk factors while 140 (34%) did not. Patients without risk factors were more likely to be older, female and have hyperlipidemia or coronary artery disease (p < 0.004). These patients had larger tumors and were more likely to undergo major hepatectomy (p < 0.001). There was no difference in OS (5-year, 56% vs 47%, p = 0.335), RFS (27% vs 24%, p = 0.398), or the rates of intrahepatic (HR:1.16 [95%CI:0.95-1.57], p = 0.344) and extrahepatic recurrences (HR:0.72 [95%CI:0.4-1.3], p = 0.261) between groups. CONCLUSION: Patients without risk factors for HCC presented with larger tumors yet had similar outcomes, suggesting these tumors may represent a different disease process, and underlying liver dysfunction can influence overall outcome.

Duke Scholars

Published In

HPB (Oxford)

DOI

EISSN

1477-2574

Publication Date

January 2021

Volume

23

Issue

1

Start / End Page

118 / 126

Location

England

Related Subject Headings

  • Survival Rate
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Neoplasm Recurrence, Local
  • Liver Neoplasms
  • Humans
  • Hepatectomy
  • Female
  • Carcinoma, Hepatocellular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McIntyre, C. A., Chou, J. F., Gonen, M., Shia, J., Gambarin-Gelwan, M., Balachandran, V. P., … D’Angelica, M. I. (2021). Hepatocellular carcinoma in patients with no identifiable risk factors. HPB (Oxford), 23(1), 118–126. https://doi.org/10.1016/j.hpb.2020.05.005
McIntyre, Caitlin A., Joanne F. Chou, Mithat Gonen, Jinru Shia, Maya Gambarin-Gelwan, Vinod P. Balachandran, T Peter Kingham, et al. “Hepatocellular carcinoma in patients with no identifiable risk factors.HPB (Oxford) 23, no. 1 (January 2021): 118–26. https://doi.org/10.1016/j.hpb.2020.05.005.
McIntyre CA, Chou JF, Gonen M, Shia J, Gambarin-Gelwan M, Balachandran VP, et al. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB (Oxford). 2021 Jan;23(1):118–26.
McIntyre, Caitlin A., et al. “Hepatocellular carcinoma in patients with no identifiable risk factors.HPB (Oxford), vol. 23, no. 1, Jan. 2021, pp. 118–26. Pubmed, doi:10.1016/j.hpb.2020.05.005.
McIntyre CA, Chou JF, Gonen M, Shia J, Gambarin-Gelwan M, Balachandran VP, Kingham TP, Allen PJ, Drebin JA, Jarnagin WR, D’Angelica MI. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB (Oxford). 2021 Jan;23(1):118–126.
Journal cover image

Published In

HPB (Oxford)

DOI

EISSN

1477-2574

Publication Date

January 2021

Volume

23

Issue

1

Start / End Page

118 / 126

Location

England

Related Subject Headings

  • Survival Rate
  • Surgery
  • Risk Factors
  • Retrospective Studies
  • Neoplasm Recurrence, Local
  • Liver Neoplasms
  • Humans
  • Hepatectomy
  • Female
  • Carcinoma, Hepatocellular